androgen receptor

envie a um amigo share this

Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer

Authors and Affiliations:

Filipe Pinto1,2, Nelma Pértega-Gomes3, José R. Vizcaíno4, Raquel P. Andrade5,6, Flavio M. Cárcano7,8, Rui M. Reis1,2,8

1 Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal

2 ICVS/3B’s – PT Government Associate Laboratory, Braga/Guimarães, Portugal

3 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts